31 Keywords: calcific aortic valve disease, ecto-5'-nucleotidase, ecto-nucleoside 32 triphosphate diphosphohydrolase 1, adenosine deaminase, adenosine, adenosine 33 receptors 2 1 Abstract 2 Extracellular nucleotide catabolism contributes to immunomodulation, cell 3 differentiation and tissue mineralization by controlling nucleotide and adenosine 4 concentrations and its purinergic effects. Disturbances of purinergic signaling in valves 5 may lead to its calcification. This study aimed to investigate the side-specific changes 6 in extracellular nucleotide and adenosine metabolism in the aortic valve during calcific 7 aortic valve disease (CAVD) and to identify the individual enzymes that are involved 8 in these pathways as well as their cellular origin. 9 Stenotic aortic valves were characterized by reduced levels of extracellular ATP 10 removal and impaired production of adenosine. Respectively, already reduced levels of 11 extracellular adenosine were immediately degraded further due to the elevated rate of 12 adenosine deamination. For the first time, we revealed that this metabolic pattern was 13 observed only on the fibrosa surface of stenotic valve that is consistent with the mineral 14 deposition on the aortic side of the valve. Furthermore, we demonstrated that non-15 stenotic valves expressed mostly ecto-nucleoside triphosphate diphosphohydrolase 1 16 (eNTPD1) and ecto-5'nucleotidase (e5NT), while stenotic valves ecto-nucleotide 17 pyrophosphatase/ phosphodiesterase 1, alkaline phosphatase and ecto-adenosine 18 deaminase (eADA). On the surface of endothelial cells, isolated from non-stenotic 19 valves, high activities of eNTPD1 and e5NT were found. Whereas, in valvular 20 interstitial cells, eNPP1 activity was also detected. Stenotic valve immune infiltrate was 21 an additional source of eADA. We demonstrated the presence of A1, A2a and A2b 22 adenosine receptors in both, non-stenotic and stenotic valves with diminished 23 expression of A2a and A2b in the former.
1 with 5 mL collagenase A (0.15% w/v) for 10 min at 37˚C to obtain hVEC. 5 mL of 2 Endothelial Cell Growth Medium Medium (Lonza, USA) was added to stop the action 3 of collagenase. To isolate hVIC, the valve was minced and further digested with 5 mL 4 collagenase A (0.15% w/v) for additional 45 min at 37˚C. 5 mL of DMEM (Sigma, 5 USA) supplemented with 1 mmol/L L-glutamine, 10% FBS and 1% 6 penicillin/streptomycin (v/v) (Sigma, USA) was added to neutralize the collagenase. 7 Each of the suspensions, hVEC and hVIC, was purified using mesh filters 100 μm, 70 8 μm, 40 μm and centrifuged (150 x g, 4 min). After centrifugation, hVEC pellet was 9 resuspended in EBM-2 Medium (Lonza, USA), while hVIC pellet in a standard 10 Dulbecco's Modified Eagle's medium (DMEM, Sigma, USA) supplemented with 1 11 mmol/L L-glutamine, 10% FBS and 1% penicillin/streptomycin (v/v) (Sigma, USA). 12 Cells were cultured at 37°C, in 5% CO 2 atmosphere and used for experiments at passage 13 4. 14 2.8 Stenotic aortic valve cells isolation 15 Aortic valve endothelial and interstitial cells, as well as immune infiltrate, were also 16 isolated from stenotic human aortic valves (n=3). hVEC and immune cells located in 17 the upper layers of the valve were isolated after 10 min incubation with agitation in 5 18 mL of collagenase A (0.15% w/v) at 37˚C. 5 mL of EBM-2 Medium (Lonza, USA) was 19 added to stop the action of collagenase. Aortic valve transport medium and suspension 20 obtained after the 1 st step of isolation were purified using mesh filters 100 μm, 70 μm, 21 40 μm. After centrifugation (150 x g, 4 min), pellets were resuspended in MACS buffer, 22 pooled and used for FACS analysis. hVIC and immune cells derived from the deeper 23 layers of the valve were isolated after mincing of the valve and additional digestion for 24 45 min in 5 mL of collagenase A (0.15% w/v) at 37˚C. 5 mL of DMEM (Sigma, USA) 1 supplemented with 1 mmol/L L-glutamine, 10% FBS and 1% penicillin/streptomycin 2 (v/v) (Sigma, USA) was added to neutralize the collagenase. Petri place used for 3 mincing of the tissue was washed using PBS and collected solution and suspension 4 obtained after the 2 nd step of isolation were purified using mesh filters 100 μm, 70 μm, 5 40 μm. After centrifugation (150 x g, 4 min), pellets were resuspended in MACS buffer, 6 pooled and used for FACS analysis. 7 2.9 Peripheral blood mononuclear cells isolation 8 Peripheral blood mononuclear cells (PBMC) were isolated from healthy adult donors 9 (n=3) using a Histopaque procedure. Briefly, a layer of 3 mL Histopaque 1.077 g/mL 10 (Sigma, USA) was applied to the layer of 3 mL Histopaque 1.119 g/mL (Sigma, USA) 11 in a 15-mL conical centrifuge tube. Blood was applied to the Histopaque 1.077 g/mL 12 layer and it was centrifuged at 400 x g for 30 min at room temperature. After 13 centrifugation, the upper layer was aspirated to within 0.5 cm of the opaque interface 14 containing mononuclear cells and discarded. The opaque interface was transferred into 15 a clean conical centrifuge tube and washed with 0.9 % NaCl containing 5 mM EDTA. 16 After centrifugation (250 x g, 10 min), the supernatant has been discarded and the cell 17 pellet was resuspended with HBSS. 11 different assay methods. The use of a first method (Figure S1A, S1D), which assumed 12 the incubation of entire leaflet fragment in the substrate solution, resulted in a higher 13 ATP hydrolysis, AMP hydrolysis and adenosine deamination than exposition only one 14 side (aortic side, fibrosa) of the aortic valve leaflet (method 2, Figure S1B, S1E). Since 15 the second method allows for the estimation of these activities on the fibrosa and 16 ventricularis surfaces separately this method has been used in the later part of 17 experiments. Nucleotide and adenosine degradation rates of intact non-stenotic aortic 18 valves did not differ between fibrosa and ventricularis ( Figure S1G ). In stenotic aortic 19 valves, the rate of ATP and AMP hydrolysis was lower, while adenosine deamination 20 was higher on the fibrosa than on ventricularis surface ( Figure S1H ). 21 Comparing nucleotide and adenosine degradation rates on the fibrosa surface in a larger 22 patients group that are characterized in Table 1 , we observed lower ATP and AMP 23 hydrolysis, as well as higher adenosine deamination, in stenotic aortic valve than in 1 non-stenotic ( Figure 1) . The blockade of a transmembrane nucleoside transport by 2 NBTI did not affect the rate of product formation ( Figure S2 ). Figure 2E ). However, the results obtained for nucleotide and adenosine 10 degradation rates were determined on the stenotic valve surface in the areas free of 11 calcification, as indicated for representative valves (Figures S3A, S3B ). We also 12 exhibited that the rate of extracellular nucleotide metabolism did not differ between 13 leaflets within the same non-stenotic ( Figure S3A ) and stenotic ( Figure S3B ) aortic 14 valve. Figures 5F, 5G) . Figures 6A, S6) revealed that 6 the most abundant among adenosine receptors in both non-stenotic and stenotic aortic 7 valves was receptor A2a (A2aR) (Figure 6B ). A2b and A1 receptors (A2bR, A1R) 8 occurred in smaller amounts ( Figure 6B ). While A3 receptor (A3R) was not observed 9 ( Figure 6B) . Importantly, all three adenosine receptors that were found in aortic valves 18 Another enzyme involved in extracellular ATP degradation is ecto-nucleotide 19 pyrophosphatase/ phosphodiesterase 1 (eNPP1) (18) that has been found at high levels 20 in valvular interstitial cells during CAVD. (19) In our study, we confirmed the presence 21 of eNPP1 in aortic valves by immunofluorescence and found its activity on the surface 22 of hVIC and to some extent on inflammatory cells that can infiltrate stenotic aortic 23 valve. However, these cells and, above all, valvular endothelial cells expressed also 24 eNTPD1 in our immunofluorescence, flow cytometry and biochemical studies. 25 Considering previously described increase in eNPP1 expression in CAVD (19), we 1 assume that the decreased total ATP hydrolysis on the fibrosa surface of stenotic valve 2 is the effect of diminished eNTPD1 activity, which expression was reduced in stenotic 3 valves. In recent studies, we have shown the decreased activity and protein level of 4 eNTPD1 in the homogenates of stenotic aortic valves using functional assays, 5 immunohistochemistry (47) and proteomics (48) . In addition, in this work we 16 Although these effects were evoked by the depletion of the extracellular ATP pool, they 17 could be expressed even more strongly through the cooperation of eNTPD1 with 18 adenosine-producing e5NT activity. e5NT was found in a variety of tissues, including 19 abundant activity in vascular endothelium. (51) We have demonstrated that e5NT was 20 the most important ecto-enzyme responsible for AMP hydrolysis on the surface of 21 valvular endothelial and interstitial cells, as well as on the immune cells isolated from 22 stenotic aortic valves. However, the total rate of AMP to adenosine hydrolysis and 23 hence e5NT activity was about 100 times higher on valve cells than on immune cells 24 isolated from stenotic valves. Our immunohistochemical (47) and current 25 immunofluorescence data revealed that a part of the signal for e5NT can accumulate in 24 1 the areas of calcification, while in not calcified sections of stenotic aortic valves, we 2 observed rather weak signal for this protein and its reduced activity in comparison to 3 non-stenotic valves. We also demonstrated decreased activity (47) and expression 4 (current study) of e5NT throughout the entire valve. In contrast to our results, it has 5 been reported previously that stenotic aortic valves revealed overexpression of e5NT. In stenotic aortic valve (B), valvular endothelial cells undergo transformation from
